Patritumab With Cetuximab and a Platinum Containing Therapy for Patients With Head and Neck Cancer
Clinical trial NCT02350712 · COMPLETED
Trial details
- NCT number
- NCT02350712
- Sponsor
- Daiichi Sankyo
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-03-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.